Announcements Trials
Browse Landscape

Phase

Phase 2 57Phase 1 45Phase NA 37Phase 3 25Phase 1/2 18Phase EARLY_PHASE1 6Phase 4 2Phase 2/3 1

Status

Completed 23Unknown 10Terminated 2Recruiting 2

Sponsor Class

OTHER 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 18Neoplasms 16Prostatic Neoplasms 12Neoplasm Metastasis 10Pain 9Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 8Polycystic Ovary Syndrome 7Leiomyoma 6Anemia 5Skin Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Pancreatic Neoplasms 4Ovarian Neoplasms 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia 4Carcinoma, Renal Cell 4Recurrence 3Melanoma 3Liver Neoplasms 3Kidney Neoplasms 3Keratosis, Actinic 3Insulin Resistance 3Carcinoma, Hepatocellular 3Cancer Pain 3Brain Neoplasms 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Stomach Neoplasms 2

Interventions

Panitumumab 1IFL protocol 1Folfox protocol 1FOLFOXIRI protocol 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Terminated × Colonic Neoplasms × Clear all
NCT02015923 2021-03-16

CCRe-IV

Hospital Universitari de Bellvitge

Phase 4 Terminated
107 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis

NCT00216424 2007-11-12

Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma

James A. Haley Veterans Administration Hospital

Phase 4 Terminated
40 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡